Headquartered in Steinfurt (with operations based in Heilbad Heiligenstadt), Germany, curea medical has established itself as a key player in the advanced wound dressing sector, catering to homecare providers, hospitals, and pharmacies across Europe, with Germany as its core market. The Company benefits from the proprietary SuperCore® superabsorbent technology, widely regarded as a benchmark in modern wound care for superior exudate management. Compared to conventional foam dressings, curea’s superabsorbent dressings offer significantly enhanced absorption and retention capacity, providing superior patient outcomes.
Founded in 2010 and with more than 50 employees, curea medical has demonstrated consistent and robust growth, achieving double-digit annual organic revenue growth rates in recent years. This performance is driven by favorable market trends and the Company’s distinctive niche positioning as specialist provider of advanced wound care dressings.
Buyout
Current
Europe
Majority
Medical Devices
2025
Status
Creation Date
Number of Employees
Investment Date
Fund Name